Get started
Author

Mohamed A. Abdelrahman

Observed names: Abdelrahman, Mohamed A., Mohamed A Abdelrahman, Mohamed A. Abdel-Rahman, Mohamed Abdelrahman
ORCID: 0000-0002-4205-0538
Observed ORCID: 0000-0002-4205-0538
OpenAlex ID: A5043279509
Novel coumarin-6-sulfonamides as apoptotic anti-proliferative agents: synthesis, in vitro biological evaluation, and QSAR studies
2018 · Ahmed Sabt, Omaima M. Abdelhafez, et al. · Journal of Enzyme Inhibition and Medicinal Chemistry · 112
Design, synthesis and 2D QSAR study of novel pyridine and quinolone hydrazone derivatives as potential antimicrobial and antitubercular agents
2017 · Mohamed A. Abdelrahman, Ismail Salama, et al. · European Journal of Medicinal Chemistry · 103
Novel 3-substituted coumarins as selective human carbonic anhydrase IX and XII inhibitors: Synthesis, biological and molecular dynamics analysis
2020 · Mohamed A. Abdelrahman, Hany S. Ibrahim, et al. · European Journal of Medicinal Chemistry · 69
Development of Novel Isatin-Tethered Quinolines as Anti-Tubercular Agents against Multi and Extensively Drug-Resistant Mycobacterium tuberculosis
2022 · Mohamed A. Abdelrahman, Hadia Almahli, et al. · Molecules · 35
PDF
Importance of glutamine 189 flexibility in SARS-CoV-2 main protease: Lesson learned from in silico virtual screening of ChEMBL database and molecular dynamics
2021 · Mohamed A. Said, Amgad Albohy, et al. · European Journal of Pharmaceutical Sciences · 35
PDF
Synthesis, biological evaluation and in silico studies with 4-benzylidene-2-phenyl-5(4H)-imidazolone-based benzenesulfonamides as novel selective carbonic anhydrase IX inhibitors endowed with anticancer activity
2019 · Wagdy M. Eldehna, Mohamed A. Abdelrahman, et al. · Bioorganic Chemistry · 35
Application of hydrazino and hydrazido linkers to connect benzenesulfonamides with hydrophilic/phobic tails for targeting the middle region of human carbonic anhydrases active site: Selective inhibitors of hCA IX
2019 · Heba Abdelrasheed Allam, Samar H. Fahim, et al. · European Journal of Medicinal Chemistry · 30
Insights into the effect of elaborating coumarin-based aryl enaminones with sulfonamide or carboxylic acid functionality on carbonic anhydrase inhibitory potency and selectivity
2022 · Hany S. Ibrahim, Mohamed A. Abdelrahman, et al. · Bioorganic Chemistry · 29
Development of pyrazolo[1,5-a]pyrimidine-grafted coumarins as selective carbonic anhydrase inhibitors and tubulin polymerization inhibitors with potent anticancer activity
2025 · Mahmoud S. Elkotamy, Mohamed A. Abdelrahman, et al. · International Journal of Biological Macromolecules · 28
A patent review of anticancer CDK2 inhibitors (2017–present)
2022 · Mohamed A. Said, Mohamed A. Abdelrahman, et al. · Expert Opinion on Therapeutic Patents · 27
Novel Diamide-Based Benzenesulfonamides as Selective Carbonic Anhydrase IX Inhibitors Endowed with Antitumor Activity: Synthesis, Biological Evaluation and In Silico Insights
2019 · Mohamed A. Abdelrahman, Wagdy M. Eldehna, et al. · International Journal of Molecular Sciences · 23
PDF
Novel benzofuran-based sulphonamides as selective carbonic anhydrases IX and XII inhibitors: synthesis and in vitro biological evaluation
2019 · Mohamed A. Abdelrahman, Wagdy M. Eldehna, et al. · Journal of Enzyme Inhibition and Medicinal Chemistry · 21
Remdesivir analog as SARS-CoV-2 polymerase inhibitor: virtual screening of a database generated by scaffold replacement
2022 · Mohamed A. Said, Amgad Albohy, et al. · RSC Advances · 13
PDF
Discovery of N′-(1-(coumarin-3-yl)ethylidene)benzenesulfonohydrazide as a novel wound healing enhancer: synthesis, biological assessment, and molecular modeling
2025 · Eman F. Khaleel, Heba Abdelmegeed, et al. · Frontiers in Chemistry · 5
PDF
Inhibitory Effect of Two Carbonic Anhydrases Inhibitors on the Activity of Major Cytochrome P450 Enzymes
2024 · Fawzy A. Elbarbry, Tamer M. Ibrahim, et al. · European Journal of Drug Metabolism and Pharmacokinetics · 5
Development and Validation of High-Throughput Bioanalytical Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) Method for the Quantification of Newly Synthesized Antitumor Carbonic Anhydrase Inhibitors in Human Plasma
2020 · Ahmed M. Abdel-Megied, Wagdy M. Eldehna, et al. · Molecules · 5
PDF
Multi-target pyrazolopyrimidine-coumarin derivatives as potent CA IX/XII and tubulin polymerization inhibitors: Design, synthesis, and biological evaluation
2026 · Mahmoud S. Elkotamy, Mohamed A. Abdelrahman, et al. · European Journal of Medicinal Chemistry · 4
Exploring the impact of the innovative compound 3-(3-(4-hydroxy-2-oxo-2H-chromen-3-yl)-5-(pyridin-3-yl)-1H-pyrazol-1-yl) indolin-2-one on accelerating wound recovery
2026 · Ahmed Sabt, Heba Abdelmegeed, et al. · Scientific Reports · 1
PDF
Design, synthesis, and molecular modeling of novel thiazolopyridine-based inhibitors of enoyl acyl carrier protein reductase (InhA) as anti- Mycobacterium tuberculosis agents
2026 · Ahmed Sabt, Małgorzata Korycka-Machała, et al. · RSC Medicinal Chemistry · 1
PDF
Synthesis and Biological Evaluation of Coumarin Derivatives with Promising Anti-Cancer Activity: Computational Kinase Profiling and Molecular Modeling Analysis.
2024 · Mahmoud S. Elkotamy, Mohamed A. Abdelrahman, et al. · Egyptian Journal of Chemistry · 1
Design of 4-(piperazin-1-yl)thieno[2,3-d]pyrimidine derivatives targeting the DFG-out conformation of VEGFR-2: Synthesis, biological evaluations, and molecular modeling approaches
2026 · Abdulrahman M. Saleh, Wagdy M. Eldehna, et al. · European Journal of Medicinal Chemistry
Inhibition of Major Cytochrome P450 Enzyme Activities in Human Liver Microsomes by 9‐a and WES‐1, two Novel Carbonic Anhydrase Inhibitors.
2020 · Van Nguyn, Michael Espiritu, et al. · The FASEB Journal
Works count: 24
Citation count: 613
H-index: 13
I10-index: 14
Year
Topic
Type